In the the latest examine, we documented the identification and the characterization of a new atypical opioid receptor with exclusive adverse regulatory Homes in the direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for